Diagnos Inc's stock has seen a steady rise, reflecting positive momentum and upcoming shareholder engagement.
Diagnos Inc (ADK.V) experienced a modest gain this week, closing at C$0.49, up 2.08% from the previous day. The stock has appreciated 5.38% over the past month and a notable 36.11% year-to-date, indicating strong performance in the health care sector. This week’s price action is supported by a significant increase in trading volume, which may indicate growing investor interest.
Advertisement
Diagnos Inc
ADK.V
ADK.V
Diagnos Inc
WealthAwesomeMarket cap
$59.31M
52W high
$0.53
52W low
$0.18
1W change
+2.08%
Beta
0.05
Analyst Price Targets
Based on analyst covering ADK · as of Sep 17, 2026
Wall Street analysts forecast ADK stock price to rise 206.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.50
+206.1% Upside
Current Price
C$0.49
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ADK's historical volatility
30-Day Vol
75.2%
Annualized
90-Day Vol
77.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.59
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.52 | C$0.40 – C$0.67 |
| 60 trading days | C$0.55 | C$0.38 – C$0.80 |
| 90 trading days | C$0.59 | C$0.37 – C$0.92 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With a solid upward trend and upcoming events, Diagnos Inc may present an intriguing opportunity for investors looking into the health care sector, despite some underlying financial challenges.
Diagnos Inc's stock is up 36.11% year-to-date.
The stock's 52-week range highlights its volatility, with current prices sitting at 89% of the range, suggesting it is approaching its recent highs.
Bull case
Analysts have a positive outlook for Diagnos Inc, setting an average target of C$1.50. This suggests a potential upside of over 200%, which could attract more investors looking for growth opportunities.
Bear case
Despite the recent price gains, Diagnos Inc faces challenges with negative profit margins and a high return on equity. These factors may raise concerns for risk-averse investors who prefer more stable investments.
Recent Price Action
Diagnos Inc's stock closed at C$0.49, marking a 2.08% increase for the day and the week. The stock has shown consistent growth over the month, up 5.38%, and has performed significantly well year-to-date, gaining 36.11%. This upward trend is notable within the context of the health care sector's overall performance.
Catalyst for Movement
Advertisement
The recent price action can be attributed to a combination of increased trading volume and investor anticipation surrounding the company's upcoming Annual General Meeting of Shareholders scheduled for September 30, 2026. This event often serves as a platform for management to outline future strategies, which can positively influence investor sentiment.
Technical Picture
From a technical standpoint, Diagnos Inc is currently trading well above its 50-day moving average of C$0.38 and its 200-day moving average of C$0.30, indicating strong bullish momentum. The stock's 52-week range of C$0.18 – C$0.53 shows it is currently at 89% of its range, suggesting it is nearing its recent peak. With a beta of 0.05, the stock exhibits low volatility compared to the broader market, making it a potentially stable investment.
Volume Insights
The latest trading volume for Diagnos Inc was 415,089 shares, significantly higher than the 20-day average volume of 246,427 shares. This 1.68x increase in volume indicates increased investor interest and activity, suggesting a strengthening of market sentiment towards the stock.
Price Action Summary
As of the last close, Diagnos Inc's stock is priced at C$0.49, reflecting a steady upward movement of 2.08% in the past day. Investors may want to keep an eye on upcoming developments as the company approaches its annual shareholder meeting.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
